Selexipag for the treatment of connective tissue disease-associated pulmonary arterial hypertension. [electronic resource]
Producer: 20180517ISSN:- 1399-3003
- Acetamides -- administration & dosage
- Adult
- Antihypertensive Agents -- administration & dosage
- Disease Progression
- Double-Blind Method
- Female
- Humans
- Hypertension, Pulmonary -- diagnosis
- Lupus Erythematosus, Systemic -- complications
- Male
- Middle Aged
- Outcome Assessment, Health Care
- Pyrazines -- administration & dosage
- Risk Assessment
- Scleroderma, Systemic -- complications
- Survival Analysis
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.